Understanding Your Rheumatology Blood Work

Why we order blood work

Rheumatology involves conditions that can’t always be seen on an X-ray or felt on an exam. Blood tests give us a window into what your immune system is doing, whether inflammation is active, and whether your medications are being tolerated safely.

But here’s the most important thing to understand: lab results are tools, not diagnoses. A single abnormal number doesn’t mean you have a disease, and a normal number doesn’t always mean everything is fine. We interpret your labs in the context of your symptoms, your exam, and your history — never in isolation.

ANA (antinuclear antibody)

The ANA test is one of the most commonly ordered tests in rheumatology — and one of the most commonly misunderstood. A positive ANA is the single most common reason patients are referred to us, and the majority of the time it turns out to be clinically meaningless.

Here’s what the test actually does: the lab takes your blood and splashes it onto healthy, normal human cells. Then they look to see if any of your antibodies stick to those cells. Antibodies are tools of your immune system — they’re designed to target bacteria, viruses, and other invaders. They are not intended to target your own cells. But sometimes they do.

Here’s the key: when antibodies stick to your own cells, it usually doesn’t matter. Up to 25% of healthy adults have a positive ANA — roughly 1 in 4 people. That’s because the ANA test detects approximately 150 different antibodies, and the vast majority of them target junk tissue or irrelevant cellular components that don’t actually trigger damage or cause autoimmune disease. They’re there, they stick, and nothing happens.

Occasionally, though, the antibodies that stick are ones that matter — ones that can trigger real inflammation and tissue damage. That’s when a positive ANA becomes clinically significant, and that’s what we’re trying to sort out.

• ANA results include a titer (like 1:80, 1:160, 1:640). Higher titers are statistically more likely to be clinically significant, but even a high titer can be meaningless in someone with no symptoms. A low titer (1:40 or 1:80) in a healthy person is almost never significant.
• Results may also include a pattern (homogeneous, speckled, nucleolar, centromere). Certain patterns point toward specific conditions, which helps guide further testing.

Sorting out which antibodies matter

When an ANA is positive, we often order ENA (extractable nuclear antigen) testing to identify the specific antibodies that were detected. This is how we figure out whether your positive ANA is one of the harmless ones or one that points toward a real condition:

• Anti-dsDNA — strongly associated with lupus (SLE) and often correlates with disease activity, particularly kidney involvement
• Anti-Smith (Sm) — highly specific for lupus (when positive, it’s almost always lupus — but most lupus patients are negative for it)
• Anti-SSA (Ro) and anti-SSB (La) — associated with Sjögren’s syndrome and lupus
• Anti-RNP — associated with mixed connective tissue disease and lupus
• Anti-Scl-70 — associated with scleroderma (diffuse type)
• Anti-centromere — associated with limited scleroderma (CREST syndrome)
• Anti-Jo-1 — associated with myositis (inflammatory muscle disease)

If the ANA is positive but all the specific antibodies are negative and you feel fine, that’s very reassuring — it usually means your immune system is producing some of those 150 harmless antibodies that stick to cells but don’t cause trouble.

A positive ANA is a starting point for investigation, not a final answer. Many patients are referred to rheumatology for a positive ANA and leave with reassurance that nothing is wrong. If that’s you, it’s genuinely good news.

RF and anti-CCP

Rheumatoid factor (RF) and anti-CCP antibodies (also called ACPA) are the two main blood tests we use when evaluating for rheumatoid arthritis.

• RF is an older test. It’s positive in about 70–80% of RA patients, but it can also be positive in other conditions — infections, liver disease, even in healthy older adults.
• Anti-CCP is more specific to RA. If this test is positive, the likelihood of RA is much higher.
• When both are positive — especially at high levels — we call this seropositive RA. Seropositive RA tends to be more aggressive and may warrant earlier, more assertive treatment.
• Some patients have RA with negative RF and anti-CCP. This is called seronegative RA. It’s still real RA — the diagnosis is made based on the full clinical picture.

ESR and CRP

ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein) are markers of inflammation in the body. They don’t tell us where the inflammation is or what’s causing it — they tell us that something is going on.

• CRP responds quickly. It rises within hours of an inflammatory trigger and falls quickly when inflammation resolves. It’s useful for tracking disease activity in real time.
• ESR moves more slowly — it may take days to rise and weeks to normalize. It gives us a broader picture of how things have been trending.
• We often trend these over time rather than reacting to a single value. A CRP that’s been gradually climbing tells a different story than one that spiked once.
• Many things besides rheumatic disease can raise these markers — infections, recent surgery, obesity, even normal aging.

CBC (complete blood count)

The CBC is a routine blood test that counts your red cells, white cells, and platelets. In rheumatology, we order it regularly for two reasons:

• Monitoring for medication effects. Many immunosuppressive medications — including methotrexate, leflunomide, and biologics — can lower your white blood cell count (WBC), which is your body’s infection-fighting army. A significant drop means we may need to adjust your dose.
• Watching platelets. Some medications can suppress platelet production. We also watch for unusually high platelet counts, which can be a sign of active inflammation.
• Anemia screening. Chronic inflammation can cause a specific type of anemia called anemia of chronic disease. If your red blood cell count is low, it may reflect poorly controlled disease activity rather than iron deficiency.

CMP (comprehensive metabolic panel)

The CMP checks your liver function, kidney function, and basic electrolytes. We order it regularly because many rheumatology medications are processed through the liver or kidneys.

• Liver enzymes (AST, ALT): Medications like methotrexate, leflunomide, and some biologics can stress the liver. We watch these numbers closely, especially in the first few months of a new medication. Mild elevations are common and usually manageable — significant elevations may require a dose change.
• Kidney function (creatinine, GFR): Your kidneys clear many of our medications. Impaired kidney function can change how we dose certain drugs — particularly allopurinol and NSAIDs. We also watch kidney function in conditions like lupus, where kidney involvement is a serious concern.
• Electrolytes and glucose: These give us a general picture of your metabolic health and can flag issues related to prednisone use — such as elevated blood sugar.

How often do we check labs?

This depends on your diagnosis and what medications you’re taking. In general:

• Every 2–4 weeks when starting a new immunosuppressive medication
• Every 3 months once you’re stable on treatment
• More frequently if we adjust doses or if something looks off

We’ll always tell you when your next labs are due. If you’re getting blood work done elsewhere — at an urgent care, your primary care office, or the ER — let us know so we can review those results too.

What if something is abnormal?

A single abnormal lab value is rarely cause for alarm on its own. We look at the trend, the degree of abnormality, and how you’re feeling clinically. If something needs attention, we’ll contact you — and if adjustments are needed, we’ll walk you through the plan.

If you have questions about a specific result, bring them to your next visit or send us a message. We’d rather explain a number that worries you than have you lose sleep over something that turns out to be insignificant.

This handout is provided for educational purposes and does not replace individualized medical advice. Always follow the specific instructions given by your rheumatologist.